Improving diabetes treatment for breast cancer survivors
Optimizing diabetes treatment strategies in complex comorbidity
['FUNDING_CAREER'] · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · NIH-11051853
This study is looking at the best ways to manage type 2 diabetes for breast cancer survivors, helping to find treatment options that work well for their unique health needs.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11051853 on ClinicalTrials.gov |
What this research studies
This research focuses on optimizing treatment strategies for type 2 diabetes (T2DM) specifically in breast cancer survivors, who often face unique health challenges due to their cancer history. The study aims to develop a simulation model that reflects the natural history and management of T2DM in this population, taking into account factors like age, cancer stage, and previous treatments. By evaluating different treatment approaches, the research seeks to identify the most effective strategies for managing diabetes while considering the potential risks associated with cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer survivors who also have type 2 diabetes.
Not a fit: Patients who do not have a history of breast cancer or do not have type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and better overall health outcomes for breast cancer survivors.
How similar studies have performed: Previous research has shown that tailored treatment strategies for comorbid conditions in cancer survivors can lead to significant improvements in patient outcomes.
Where this research is happening
NEW YORK, UNITED STATES
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEITER, AMANDA CANDICE — ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
- Study coordinator: LEITER, AMANDA CANDICE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: adult onset diabetes, Adult-Onset Diabetes Mellitus, anti-cancer therapy